Peramivir and laninamivir susceptibility of circulating influenza A and B viruses-Reference-Cited by-同舟云学术

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses

Published:2013-11-07 Issue:2 Volume:8 Page:135-139
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Leang Sook-Kwan¹,Kwok Simon¹,Sullivan Sheena G.¹,Maurer-Stroh Sebastian²³⁴,Kelso Anne¹,Barr Ian G.¹⁵,Hurt Aeron C.¹⁵

Affiliation:

1. WHO Collaborating Centre for Reference and Research on Influenza; North Melbourne Vic. Australia

2. Bioinformatics Institute (BII); Agency for Science; Technology and Research (A*STAR); Singapore City Singapore

3. School of Biological Sciences (SBS); Nanyang Technological University (NTU); Singapore City Singapore

4. National Public Health Laboratory (NPHL); Communicable Diseases Division; Ministry of Health (MOH); Singapore City Singapore

5. School of Applied Sciences and Engineering; Monash University; Churchill Vic. Australia

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Reference22 articles.

1. Centers for Disease Control and Prevention Influenza antiviral medications: summary for clinicians 2012 http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm

2. Peramivir for the treatment of influenza;Shetty;Expert Rev Anti Infect Ther,2012

3. BioCryst Pharmaceuticals I Peramivir (Neuraminidase Inhibitor) 2013 http://www.biocryst.com/peramivir

4. ChinaBioToday China's SFDA ready to fast-track approvals of peramivir, a flu treatment 2013 http://www.chinabiotoday.com/articles/20130408_1

5. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza;Birnkrant;N Engl J Med,2009

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Development History, Structural Composition, and Functions of Influenza Viruses and the Progress of Influenza Virus Inhibitors in Clinics and Clinical Trials;Mini-Reviews in Medicinal Chemistry;2024-08-07

2. Antiviral resistance in influenza viruses;Cellular and Molecular Biology;2023-12-10

3. Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo;mSystems;2023-10-26

4. Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy;Microorganisms;2023-01-11

5. Antiviral Agents;Principles and Practice of Pediatric Infectious Diseases;2023